A NOVEL APPROACH TO SAFER GLUCOCORTICOID RECEPTOR-TARGETED ANTI-LYMPHOMA THERAPY VIA RED D1 (REGULATED IN DEVELOPMENT AND DNA DAMAGE 1) INHIBITION ArticleLesovaya E.A., Savinkova A.V., Morozova O.V., Lylova E.S., Zhidkova E.M., Kulikov E.P., Kirsanov K.I., Klopot A., Baida G., Yakubovskaya M.G., Gordon L.I., Ben Readhead, Dudley J.T., Budunova I.MOLECULAR CANCER THERAPEUTICS. Том 19. 2020. С. 1898-1908